Regional Changes in the Type 1 Cannabinoid Receptor Are Associated With Cognitive Dysfunction in Parkinson's Disease

Key Findings:  PET scan of participating Parkinson's patients showed decreased CB1 receptor sites in portions of the brain strongly correlated with ill-effects in executive functioning, episodic memory, and visuospatial functioning.

Type of Study:  Meta-analysis

Study Sample Size:  38

Study Result:  Inconclusive

Cannabinoids Studied:  Not Applicable

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Receptors Studied:  CB1

Study Location(s):  Belgium

Year of Pub:  2019

Link to study